Debt Financing for early-stage Biotech Life Sciences companies

Smartlabs, 40 Guest St, 02135, Boston, United States
See on map

Price: FACCNE, GABC SACCNE Members: $32;
General Registration $47.
Platinum Members can register 3 attendees at no cost, please contact


Event ended.

An exceptional panel with collectively over 100 years of relevant experience!

At a time when raising capital may be challenging, Life Sciences and Biotech startups & early-growth stage companies should evaluate debt financing, a form of capital that is more traditionally used by early-stage tech companies or companies generating steady streams of cash flows.   During a panel discussion with our seasoned experts, we will reflect on:

  • Is debt financing the right instrument to grow your biotech or life sciences company?

  • When should life sciences/biotech startups and early-growth stage companies consider debt financing?

  • What are the pros and cons of raising debt versus equity?

  • What financing structures are available?

The panel discussion will be preceded by a tour of the Smartlabs facilities at Boston Landing: Join us at 5pm to learn how they deliver flexible turnkey lab programs to support workflows at every stage of development.  

This event is supported by KeyBank.

📆  Date: Tuesday, April 9, 2024
🕔  Time:

  • 5 pm - Private tour of SmartLabs state-of-the-art facilities
  • 6 pm - Panel Discussion, followed by networking cocktail

📍  Location: Smartlabs, (3rd floor) 40 Guest St, 02135, Boston, (directions), onsite parking available (access behind the building)
🎫  Registration:  $32 for FACCNE, GABC & SACCNE members; $47 for non-members. Platinum Members can register 3 attendees at no cost, please contact events(@)

Sign up early  as space is limited!

Tickets for this event are transferable but not refundable, 48 hours before the event.

Meet our speakers !

Moderator: Paul Enderle, Founder and Managing Director, BayCross Capital Group.
With 30 years of experience in strategy and venture capital, Paul helps address unmet capital needs for emerging companies in the venture, middle market, and small-cap public markets.


🎤 Marc de GaridelCEO, Abivax
With over 30 years of industry experience, including 12 years as CEO, Marc's expertise includes both debt financing (his current company secured $150m in debt financing from two structured debt financing transactions in 2023) and equity financing (largest French biotech IPO ever on Nasdaq).

🎤 Seth Taylor, Co-founder and Chief Business Officer, SmartLabs
SmartLabs is a series C company that makes capital investments in enterprise-grade R&D infrastructure, and provides them as service to biotech firms.  Seth Taylor is also the founder of Boston's most popular biotech networking event, BiotechTuesday.

🎤 Janice Bourque, Managing Director, Life Sciences, Hercules Capital
Janice is a former president and CEO of MassBio, an organization dedicated to life sciences leadership. She providesventure debt and equity to venture capital and private equity-backed life science companies at all stages of development.

🎤 Nate Meaux Head of Northeast Biopharma, Diagnostics and Tools, Silicon Valley Bank
Expert in venture debt facilities underwriting at SVB, whose experience over the last 10 years has spanned over $1Bn in commitments.


This event is supported by

Thank you for hosting us

About SmartLabs:

SmartLabs is accelerating the pace of scientific discovery by radically transforming the way the world builds and uses lab space. Where lab construction can take 9 to 12 months in the traditional process, we deliver personalized and effective lab workflow environments in about 4 weeks. This huge reduction in time means member teams are starting sooner and results are delivered faster. We continue to compound this time savings with our proactive operational support and ability to pivot and change lab space quickly as member science evolves and lab needs change.

We love what we do - our members are shaping the future and we are proud to help them do it! We currently have locations in the MIT area of Cambridge, at Innovation Square in the Boston Seaport, in the hot new development at Boston Landing, and in South San Francisco. Visit our website to request a tour.

Event Location

Transportation: Framingham/Worcester Commuter rail, Boston Landing Station

Underground parking operated by Propark (access behind the building) 

Share this page Share on FacebookShare on TwitterShare on Linkedin